subject: CHEBI:119915

subject_name: Fentanyl

object_name: Postoperative Pain, Acute


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Atypical behavior

tested_intervention: yes


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: type 1 diabetes mellitus 1

tested_intervention: unsure


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UMLS:C5417927


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: sensorineural hearing loss disorder


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C2984518

subject_name: tabalumab

object_name: chronic kidney disease


subject: UMLS:C2984518

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine

object_name: Tourette syndrome


subject: UMLS:C4745334

subject_name: JAK1 Inhibitor AZD4205

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: pouchitis


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant

object_name: inborn mitochondrial metabolism disorder


subject: PUBCHEM.COMPOUND:71364

object_name: mitochondrial disease


subject: PUBCHEM.COMPOUND:71364

object_name: Haemodialysis-induced symptom


subject: CHEBI:32127

subject_name: sevelamer

object_name: type 2 diabetes mellitus


subject: CHEBI:32127

object_name: Insulin resistance


subject: CHEBI:32127


subject: CHEBI:32127


subject: CHEBI:32127

object_name: end stage renal failure


subject: CHEMBL.COMPOUND:CHEMBL5314349

subject_name: SEVELAMER


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:9YCX42I8IU


subject: UNII:9YCX42I8IU


subject: UNII:9YCX42I8IU


subject: UNII:9YCX42I8IU


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: gastroenteritis


subject: UMLS:C3819106

object_name: Cross Infection


subject: UMLS:C3819106

object_name: diarrhea


subject: UMLS:C3819106

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C3819106

object_name: Diarrhea, CTCAE


subject: UMLS:C0036088

subject_name: Artificial saliva

object_name: Xerostomia


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Peripheral neuropathic pain


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: acute myocardial infarction


subject: UMLS:C3714501

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: MESH:D003069

subject_name: Coffee

object_name: Burnout, Professional


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: paroxysmal nocturnal hemoglobinuria


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UMLS:C0247952

object_name: colorectal carcinoma


subject: UMLS:C0247952

object_name: Embolism, Tumor


subject: UMLS:C0247952

object_name: Neoplasm Metastasis


subject: UMLS:C0247952

object_name: Metastatic Lesion


subject: UMLS:C0247952

object_name: colorectal neoplasm


subject: CHEBI:80308

subject_name: substance P

object_name: diarrhea with hiv


subject: CHEBI:80308

object_name: HIV enteropathy


subject: UNII:PY79D6C8RX

subject_name: Crofelemer


subject: UNII:PY79D6C8RX


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: endogenous depression


subject: CHEBI:17045

object_name: major depressive disorder


subject: CHEBI:17045

object_name: treatment resistant depression


subject: CHEBI:17045


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: alopecia areata


subject: UNII:DLG4EML025

object_name: alopecia


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: cervical carcinoma


subject: UNII:FE7L22H028

subject_name: ZALIFRELIMAB


subject: UNII:FE7L22H028


subject: PUBCHEM.COMPOUND:22950330

subject_name: Methylcellulose

object_name: irritable bowel syndrome


subject: CHEMBL.COMPOUND:CHEMBL2109198

subject_name: METHYLCELLULOSE


subject: DRUGBANK:DB11097

subject_name: Plantago seed


subject: CHEBI:165446

subject_name: Psyllic acid


subject: UNII:FNO32LO217

subject_name: HUMAN INTERLEUKIN-2

object_name: triple-negative breast carcinoma


subject: UNII:FNO32LO217

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: acute coronary syndrome


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IV Nasopharyngeal Carcinoma


subject: CHEBI:231614

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:231614

object_name: Metastatic Nasopharyngeal Undifferentiated Carcinoma


subject: CHEBI:231614

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Metastatic Nasopharyngeal Non-Keratinizing Carcinoma


subject: CHEBI:231614

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:92043599

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:92043599

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:6801

subject_name: Metformin

object_name: adult hepatocellular carcinoma


subject: CHEBI:6801

object_name: liver cancer


subject: CHEBI:6801

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:6801

object_name: pancreatic neoplasm


subject: CHEBI:6801

object_name: exocrine pancreatic carcinoma


subject: CHEBI:6801

object_name: malignant pancreatic neoplasm


subject: CHEBI:6801

object_name: colorectal carcinoma


subject: CHEBI:6801

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6801

object_name: Stomach cancer


subject: CHEBI:6801

object_name: gastric cancer


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290

object_name: liver carcinoma


subject: CHEBI:38290


subject: CHEBI:38290

object_name: colorectal cancer


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: MESH:C000588783

subject_name: shanchol

object_name: cholera


subject: MESH:C000588783

object_name: Miscarriage


subject: MESH:C000588783

object_name: spontaneous abortion


subject: MESH:C000588783

object_name: abortion


subject: MESH:C000588783

object_name: Fetal Death


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: cataract


subject: CHEBI:3515

object_name: Cataract, CTCAE 3.0


subject: CHEBI:3515

object_name: Cataract, CTCAE 5.0


subject: CHEBI:3515

object_name: cataract on exam (physical finding)


subject: CHEBI:3515

object_name: endophthalmitis


subject: CHEBI:3515

object_name: Endophthalmitis, CTCAE


subject: CHEBI:6904

subject_name: Metoprolol

object_name: interstitial cystitis


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: UMLS:C3659413

object_name: type 1 diabetes mellitus


subject: CHEBI:151315

subject_name: Heparin

object_name: preeclampsia


subject: GTOPDB:6803

subject_name: dalteparin


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: CHEBI:230796

subject_name: Orvepitant

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: Stage IV Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: Stage III Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: Stage IIIA Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2791

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:2791

object_name: colon adenocarcinoma


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:567361

subject_name: Cladribine

object_name: adult lymphoma


subject: CHEBI:567361

object_name: lymphoma


subject: CHEBI:567361

object_name: pediatric lymphoma


subject: CHEBI:9329

subject_name: Sulfadoxine

object_name: Fasting


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: dry eye syndrome


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C2745498

object_name: pancreatic neoplasm


subject: CHEBI:77590

subject_name: Armodafinil

object_name: sleep apnea


subject: CHEBI:77590

object_name: Sleep Apnea, CTCAE


subject: CHEBI:77590

object_name: insomnia


subject: CHEBI:77590

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:77590

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:31859


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: uveal melanoma


subject: PR:000001151

object_name: uvea neoplasm


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4727690

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Arthralgia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Joint Pain, CTCAE


subject: UMLS:C5448936

subject_name: Tart Cherry

object_name: Childhood Breast Carcinoma


subject: UMLS:C5448936

object_name: breast carcinoma


subject: UMLS:C5448936

object_name: breast cancer


subject: UMLS:C5448936


subject: UMLS:C5448936


subject: PUBCHEM.COMPOUND:126480208

subject_name: Ganfort

object_name: glaucoma


subject: PUBCHEM.COMPOUND:126480208

object_name: Glaucoma, CTCAE


subject: UMLS:C5815531

subject_name: VaxSyn

object_name: HIV Seronegativity


subject: UMLS:C5815618

subject_name: Gp160 Vaccine


subject: CHEBI:36796

subject_name: duloxetine

object_name: irritable bowel syndrome


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:7XL5ISS668

object_name: Follicular B-cell non-Hodgkin's lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: plasma cell myeloma


subject: CHEBI:72317

object_name: Plasma cell myeloma refractory


subject: CHEBI:72317

object_name: Relapsed/refractory multiple myeloma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: uterine fibroid


subject: CHEBI:6801

subject_name: Metformin

object_name: Hypercholesterolemia


subject: CHEBI:41423

subject_name: Celecoxib

object_name: glioma


subject: CHEBI:41423

object_name: malignant glioma


subject: CHEBI:38562

subject_name: Fluvastatin


subject: CHEBI:38562


subject: CHEBI:64019

subject_name: Nebivolol

object_name: Heart failure with normal ejection fraction


subject: CHEBI:64019

object_name: pulmonary hypertension


subject: CHEBI:64019

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:64019

object_name: diastolic heart failure


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: small cell carcinoma


subject: UMLS:C3827082


subject: CHEBI:31355

subject_name: Carboplatin


subject: UMLS:C5908008

subject_name: Anti-DLL3 ADC ZL-1310


subject: UMLS:C5908008

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:46783403

object_name: Chronic uremia


subject: UNII:CO86AOP337

subject_name: ETENTAMIG


subject: UMLS:C5236471


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Amyloid light-chain nephropathy


subject: CHEBI:3215

object_name: Dissecting Thoracic Aortic Aneurysm


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: UMLS:C4086546

object_name: Acute Pain


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:68564

subject_name: icatibant acetate

object_name: Pneumonia caused by SARS-CoV-2


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant


subject: UMLS:C0082926

subject_name: HOE 140


subject: CHEBI:68573

subject_name: indacaterol maleate

object_name: asthma


subject: CHEBI:32588

subject_name: Potassium chloride

object_name: Critical Illness


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:231353

subject_name: Orteronel

object_name: prostate neoplasm


subject: UMLS:C3467983


subject: CHEBI:18220

subject_name: Isoflavone

object_name: benign prostatic hyperplasia


subject: UMLS:C1568660

object_name: ovarian carcinoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Insulin hypoglycaemia


subject: UMLS:C3714501

object_name: Glucose test site bleeding


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:7465

subject_name: Naltrexone

object_name: schizophrenia


subject: CHEBI:7465

object_name: schizoaffective disorder


subject: CHEBI:7465

object_name: schizophrenia 18


subject: CHEBI:7465

object_name: schizophreniform disorder


subject: CHEBI:7465

object_name: Severe major depression with psychotic features


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Metastatic malignant neoplasm to liver


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:71301229

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:71301229


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: lung adenocarcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: multiple sclerosis


subject: UNII:69VKY8P7EA

object_name: castration-resistant prostate carcinoma


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C5667279

subject_name: Fluorine F 18 Florastamin

object_name: High Risk Prostate Carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: severe congenital neutropenia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEMBL.COMPOUND:CHEMBL4594461

subject_name: AUTOLOGOUS CORD BLOOD

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEMBL.COMPOUND:CHEMBL4594461

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:35962

subject_name: sorbic acid

object_name: lumbar disc herniation


subject: CHEBI:35962

object_name: lumbar disk disease


subject: CHEBI:35962

object_name: lumbar disk degenerative disorder


subject: CHEBI:35962

object_name: Lumbar radiculopathy


subject: CHEBI:74801

subject_name: Ser-Ala


subject: CHEBI:74801


subject: CHEBI:74801


subject: CHEBI:74801


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:16914


subject: CHEBI:16914


subject: CHEBI:16914


subject: CHEBI:45373

subject_name: Sulfanilamide


subject: CHEBI:45373


subject: CHEBI:45373


subject: CHEBI:45373


subject: PR:000003667

subject_name: acyl-coenzyme A synthetase ACSM3, mitochondrial


subject: PR:000003667


subject: PR:000003667


subject: PR:000003667


subject: PR:000001931

subject_name: sialoadhesin


subject: PR:000001931


subject: PR:000001931


subject: PR:000001931


subject: UNII:77AP23J0GH

object_name: chronic hepatitis B virus infection


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Compulsion


subject: CHEBI:6931

subject_name: Midazolam

object_name: Sedative, hypnotic, or anxiolytic withdrawal


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:137359

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: PUBCHEM.COMPOUND:11541088

subject_name: Daglutril

object_name: hypertension


subject: PUBCHEM.COMPOUND:11541088

object_name: Hypertension, CTCAE


subject: UMLS:C2348069


subject: UMLS:C2348069


subject: UMLS:C5400085

object_name: neuralgia


subject: UMLS:C5400085

object_name: Neuropathic pain


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: female infertility


subject: CHEBI:151315

subject_name: Heparin


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Complication of transplanted liver


subject: PUBCHEM.COMPOUND:25476

object_name: Vasoplegia


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Weight loss


subject: CHEBI:85078

object_name: Weight Loss, CTCAE


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Sepsis


subject: CHEBI:28918

object_name: Sepsis, CTCAE


subject: UMLS:C1963284

subject_name: Adrenalin


subject: UMLS:C1963284


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: anal fistula


subject: UMLS:C0054066

object_name: Anal Fistula, CTCAE


subject: PUBCHEM.COMPOUND:16056828

object_name: vitamin B12 deficiency


subject: CHEBI:27786

subject_name: Hydroxocobalamin


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Inguinal hernia


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:KZ3DLD11RQ

object_name: head and neck squamous cell carcinoma


subject: UNII:XNM7LT65NP

object_name: Prevention problem


subject: UNII:XNM7LT65NP

object_name: ventilator-associated pneumonia


subject: UNII:XNM7LT65NP

object_name: Respiratory infection other


subject: UMLS:C2698293

subject_name: Aztreonam lysine


subject: UMLS:C2698293


subject: UMLS:C2698293


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: hormone receptor-positive breast cancer


subject: PUBCHEM.COMPOUND:156963654

object_name: Advanced breast cancer


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: MESH:C000627770

subject_name: folfirinox

object_name: metastatic colorectal cancer


subject: UMLS:C3661051

object_name: inherited lipid metabolism disorder


subject: UMLS:C3661051

object_name: Dyslipidemia


subject: CHEBI:6832

subject_name: Methocarbamol

object_name: Low back pain


subject: CHEBI:7789

subject_name: Orphenadrine


subject: CHEBI:6801

subject_name: Metformin

object_name: endometrial undifferentiated carcinoma


subject: CHEBI:6801

object_name: undifferentiated carcinoma of the corpus uteri


subject: CHEBI:6801

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:6801

object_name: endometrial serous adenocarcinoma


subject: CHEBI:6801

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:6801

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:6801

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:6801

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: chronic pain (diagnosis)


subject: UMLS:C0678449

object_name: Chronic pain


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic HER2 positive gastroesophageal junction cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:31355

subject_name: Carboplatin

object_name: endometrial transitional cell carcinoma


subject: CHEBI:31355

object_name: transitional cell carcinoma of the corpus uteri


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355

object_name: endometrial squamous cell carcinoma


subject: CHEBI:31355

object_name: squamous cell carcinoma of the corpus uteri


subject: CHEBI:31355


subject: CHEBI:31355

object_name: endometrial mucinous adenocarcinoma


subject: CHEBI:31355


subject: CHEBI:31355

object_name: endometrioid adenocarcinoma


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:70839

object_name: endometrial undifferentiated carcinoma


subject: CHEBI:70839

object_name: undifferentiated carcinoma of the corpus uteri


subject: CHEBI:70839

object_name: endometrium adenocarcinoma


subject: CHEBI:70839

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:70839

object_name: endometrial serous adenocarcinoma


subject: CHEBI:70839

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:70839


subject: CHEBI:70839

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:70839

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:70839


subject: CHEBI:190514

object_name: endometrial transitional cell carcinoma


subject: CHEBI:190514

object_name: transitional cell carcinoma of the corpus uteri


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514

object_name: endometrial squamous cell carcinoma


subject: CHEBI:190514

object_name: squamous cell carcinoma of the corpus uteri


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514

object_name: endometrial mucinous adenocarcinoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514

object_name: endometrioid adenocarcinoma


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375

object_name: endometrial undifferentiated carcinoma


subject: CHEBI:49375

object_name: undifferentiated carcinoma of the corpus uteri


subject: CHEBI:49375

object_name: endometrium adenocarcinoma


subject: CHEBI:49375

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375

object_name: endometrial serous adenocarcinoma


subject: CHEBI:49375

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:49375


subject: CHEBI:49375

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:49375

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:49375


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: endometrial transitional cell carcinoma


subject: CHEBI:45863

object_name: transitional cell carcinoma of the corpus uteri


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: endometrial squamous cell carcinoma


subject: CHEBI:45863

object_name: squamous cell carcinoma of the corpus uteri


subject: CHEBI:45863


subject: CHEBI:45863

object_name: endometrial mucinous adenocarcinoma


subject: CHEBI:45863


subject: CHEBI:45863

object_name: endometrioid adenocarcinoma


subject: UNII:0J8RN2W0HK

subject_name: Trifarotene

object_name: acne


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: clavicle fracture


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: pancreatic neoplasm


subject: CHEBI:100241

object_name: exocrine pancreatic carcinoma


subject: CHEBI:100241

object_name: malignant pancreatic neoplasm


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: autoimmune hemolytic anemia


subject: UNII:3A189DH42V

object_name: autoimmune thrombocytopenia


subject: UNII:3A189DH42V

object_name: autoimmune thrombocytopenic purpura


subject: UNII:V5Y646AW8S

object_name: Presenile dementia


subject: UNII:V5Y646AW8S

object_name: dementia


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Erosive esophagitis


subject: CHEBI:77260

subject_name: Omeprazole


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium


subject: CHEBI:6824

subject_name: Methenamine

object_name: Chronic urinary tract infection


subject: CHEBI:15372

object_name: autism


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:149504

object_name: essential hypertension


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEMBL.COMPOUND:CHEMBL3545269

object_name: type 2 diabetes mellitus


subject: UMLS:C5882405


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Body Composition


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:27732

subject_name: Caffeine

object_name: amblyopia


subject: UNII:9J765S329G

subject_name: L-Thyroxine sodium salt pentahydrate

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:9J765S329G


subject: CHEBI:6447

subject_name: levothyroxine sodium hydrate


subject: CHEBI:6447


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UMLS:C0079691

subject_name: Levothroid


subject: UMLS:C0079691


subject: PUBCHEM.COMPOUND:132160637

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:132160637

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:132160637

object_name: mal de Debarquement


subject: PUBCHEM.COMPOUND:132160637

object_name: Minimal Disseminated Disease


subject: PUBCHEM.COMPOUND:131648253

subject_name: PEN

object_name: Primary hypercholesterolemia


subject: UNII:66Q80IL7CW

subject_name: Penclomedine


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Acute Pain


subject: CHEBI:82524

subject_name: Prednimustine

object_name: migraine


subject: CHEBI:82524

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:16410

subject_name: Pyridoxamine


subject: CHEBI:16410


subject: CHEBI:141444

subject_name: Pro-Met


subject: CHEBI:141444


subject: CHEBI:33373

subject_name: promethium atom


subject: CHEBI:33373


subject: CHEBI:53551

subject_name: poly(methylene)


subject: CHEBI:53551


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: pneumonia


subject: CHEBI:6888

object_name: COVID-19-Associated Pneumonia


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: IgA Nephropathy


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: non-small cell lung carcinoma


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: nonpapillary renal cell carcinoma


subject: UNII:QEN1X95CIX

object_name: clear cell renal carcinoma


subject: UNII:QEN1X95CIX

object_name: renal cell adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: renal cell carcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:45716

subject_name: Vorinostat

object_name: adult glioblastoma


subject: CHEBI:45716

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:45716

object_name: Adult Gliosarcoma


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:51038893

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: Solid Neoplasm


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UMLS:C3652932

subject_name: pyronaridine and artesunate drug combination


subject: CHEBI:3360

subject_name: Cannabinol

object_name: insomnia


subject: CHEBI:75934

subject_name: Vadimezan

object_name: lung cancer


subject: CHEBI:75934

object_name: lung neoplasm


subject: CHEBI:75934

object_name: lung carcinoma


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Disorder of intraocular pressure


subject: CHEBI:150712

object_name: Intraocular Pressure


subject: CHEBI:150712

object_name: corneal edema


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: PUBCHEM.COMPOUND:57503849

subject_name: Hydroxypropylmethylcellulose


subject: PUBCHEM.COMPOUND:57503849


subject: PUBCHEM.COMPOUND:57503849


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: UNII:B1QE5P712K


subject: UNII:B1QE5P712K


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: autoimmune thrombocytopenia


subject: UNII:3H8GSZ4SQL

object_name: thrombocytopenia due to immune destruction


subject: UNII:3H8GSZ4SQL

object_name: autoimmune thrombocytopenic purpura


subject: UNII:3H8GSZ4SQL

object_name: connective tissue disorder


subject: UNII:3H8GSZ4SQL

object_name: Evans syndrome


subject: CHEBI:40279

subject_name: Allopurinol

object_name: essential hypertension


subject: CHEBI:91414

subject_name: Adavosertib

object_name: prostate carcinoma


subject: CHEBI:91414

object_name: prostate cancer


subject: UNII:09OB3E5QTD


subject: UNII:09OB3E5QTD


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:95089


subject: CHEBI:231369

subject_name: Savolitinib


subject: CHEBI:231369


subject: UMLS:C3274576

subject_name: Monoclonal Antibody AbGn-7

object_name: Stomach cancer


subject: UMLS:C3274576

object_name: gastric cancer


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Congenital postural scoliosis


subject: CHEBI:3215

object_name: scoliosis


subject: CHEBI:3215

object_name: Scoliosis, CTCAE


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:24892726

object_name: obesity


subject: PUBCHEM.COMPOUND:24892726

object_name: Obesity, CTCAE


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: coronary artery disorder


subject: CHEBI:25681

object_name: coronary atherosclerosis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: trabecular adenocarcinoma


subject: CHEBI:45863

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: colorectal cancer


subject: CHEBI:6121

object_name: colorectal carcinoma


subject: CHEBI:6121

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4053627

subject_name: Anti-CD123 Monoclonal Antibody KHK2823

object_name: Myelodysplasia


subject: UMLS:C4053627

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4053627

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4053627

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4053627

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4053627

object_name: acute myeloid leukemia


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: Childhood Breast Carcinoma


subject: CHEBI:190410

object_name: breast carcinoma


subject: CHEBI:190410

object_name: breast cancer


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: CHEBI:31401

subject_name: Cilostazol

object_name: stroke disorder


subject: CHEBI:31401

object_name: cerebral infarction


subject: CHEBI:31401

object_name: cerebrovascular disorder


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:07730V90L6

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:9848990

object_name: major depressive disorder


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: UMLS:C2347292

object_name: pancreatic neoplasm


subject: UMLS:C2347292

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2347292

object_name: malignant pancreatic neoplasm


subject: UMLS:C2347292

object_name: pancreas disorder


subject: UMLS:C2347292

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:3219

subject_name: Bupropion

object_name: lung cancer


subject: CHEBI:3219

object_name: lung neoplasm


subject: CHEBI:3219

object_name: lung carcinoma


subject: CHEBI:17688

subject_name: Nicotine


subject: CHEBI:17688


subject: CHEBI:17688


subject: CHEBI:35623

subject_name: anticonvulsant

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:35623

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:35623

object_name: Adult Gliosarcoma


subject: CHEBI:35623

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C0003286

subject_name: Anticonvulsants


subject: UMLS:C0003286


subject: UMLS:C0003286


subject: UMLS:C0003286


subject: UMLS:C5890179

subject_name: Anticonvulsant


subject: UMLS:C5890179


subject: UMLS:C5890179


subject: UMLS:C5890179


subject: CHEBI:63605

subject_name: Ixabepilone


subject: CHEBI:63605


subject: CHEBI:63605


subject: CHEBI:63605


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: Miscarriage


subject: PUBCHEM.COMPOUND:3267

object_name: spontaneous abortion


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: UMLS:C5237727

subject_name: Macrocycle-bridged STING Agonist E7766

object_name: adult lymphoma


subject: UMLS:C5237727

object_name: lymphoma


subject: UMLS:C5237727

object_name: pediatric lymphoma


subject: UNII:86EEZ49YVB

subject_name: FOSTAMATINIB DISODIUM

object_name: adrenal gland pheochromocytoma


subject: UNII:86EEZ49YVB

object_name: pheochromocytoma


subject: UNII:86EEZ49YVB

object_name: renal cell carcinoma


subject: UNII:86EEZ49YVB

object_name: non-small cell lung carcinoma


subject: UNII:86EEZ49YVB

object_name: head and neck neoplasm


subject: UNII:86EEZ49YVB

object_name: colorectal neoplasm


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib


subject: UNII:SQ8A3S5101


subject: UNII:SQ8A3S5101


subject: UNII:SQ8A3S5101


subject: UNII:SQ8A3S5101


subject: UNII:SQ8A3S5101


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: UNII:O43472U9X8

object_name: granulomatosis with polyangiitis


subject: UNII:O43472U9X8

object_name: microscopic polyangiitis


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:80774

subject_name: taurursodiol


subject: PUBCHEM.COMPOUND:145948323

subject_name: ELIGLUSTAT TARTRATE

object_name: Gaucher disease


subject: CHEBI:83353

subject_name: Agalsidase beta


subject: PUBCHEM.COMPOUND:11531537

subject_name: Eliglustat


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]

object_name: autosomal recessive distal spinal muscular atrophy 1


subject: UMLS:C5575704

object_name: Charcot-Marie-Tooth disease axonal type 2S


subject: CHEBI:8378

subject_name: Prednisolone

object_name: atopic conjunctivitis


subject: CHEBI:82977

subject_name: Daclatasvir


subject: UMLS:C1095895

subject_name: Urtica preparation

object_name: urinary tract infection


subject: UMLS:C1095895

object_name: bacterial urinary tract infection


subject: UMLS:C1095895

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:17596

subject_name: Inosine

object_name: congenital diaphragmatic hernia


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Inflammatory Response


subject: CHEBI:4466

object_name: metabolic disturbance


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH

object_name: Hypoxemia


subject: UNII:7N8K34P2XH


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin


subject: CHEBI:185135

subject_name: Polyvidone

object_name: Surgical Wound Infection


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: UMLS:C5238421

subject_name: PARP Inhibitor NMS-03305293

object_name: ovarian cancer


subject: UMLS:C5238421

object_name: ovarian neoplasm


subject: UMLS:C5238421

object_name: ovarian carcinoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: plasma cell myeloma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: Prostatic Cancer, Castration-Resistant


subject: UNII:W0ZE0NT8IF

object_name: castration-resistant prostate carcinoma


subject: UNII:J6K8WSV73A

subject_name: Quemliclustat


subject: UNII:J6K8WSV73A


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole


subject: UNII:5YV419FIJS


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:74814


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:33351


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: PUBCHEM.COMPOUND:4456137

subject_name: Epothilone B

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:4456137

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:4456137

object_name: breast cancer


subject: PUBCHEM.COMPOUND:4456137

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:4456137

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:4456137

object_name: Neoplasm Metastasis


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: CHEBI:31550


subject: CHEBI:31550


subject: CHEBI:31550


subject: CHEBI:31550


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: biliary tract neoplasm


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: type 1 diabetes mellitus 1


subject: UNII:E3B2GI648A

object_name: type 1 diabetes mellitus


subject: CHEBI:93851

subject_name: Celestone

object_name: Premature birth


subject: CHEBI:93851

object_name: Complication of prematurity


subject: CHEBI:93851

object_name: premature birth (history)


subject: CHEBI:93851

object_name: pregnancy disorder


subject: CHEBI:93851

object_name: Premature Labor


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Orofacial Pain


subject: UNII:4UN9AOU6G8

object_name: Hepatic impairment


subject: PR:000023218

subject_name: methionine import ATP-binding protein MetN

object_name: HIV infection


subject: UMLS:C0169964

subject_name: somatropin

object_name: lipodystrophy


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UNII:CW657OBU4N

subject_name: thyme extract

object_name: Cough


subject: UNII:CW657OBU4N

object_name: Cough, CTCAE


subject: UNII:CW657OBU4N

object_name: common cold


subject: DRUGBANK:DB10983

subject_name: Thyme


subject: DRUGBANK:DB10983


subject: DRUGBANK:DB10983


subject: UNII:2UK410MY6B

subject_name: Thyme oil


subject: UNII:2UK410MY6B


subject: UNII:2UK410MY6B


subject: UMLS:C1170485

subject_name: Ortho Tri-Cyclen Lo


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:50815

subject_name: Norgestimate


subject: DRUGBANK:DB04904

subject_name: Amolimogene

object_name: dysplasia of cervix


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE


subject: UMLS:C1099192


subject: UMLS:C1535531

subject_name: Recombinant Thyroid-Stimulating Hormone

object_name: Neck Carcinoma


subject: UMLS:C1535531

object_name: head and neck neoplasm


subject: UMLS:C1535531

object_name: head and neck cancer


subject: DRUGBANK:DB17683


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:61080

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:61080

object_name: non-Hodgkin lymphoma


subject: CHEBI:61080

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:61080

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: adult lymphoma


subject: UNII:8M7YSN2KII

object_name: lymphoma


subject: UNII:8M7YSN2KII

object_name: pediatric lymphoma


subject: UNII:8M7YSN2KII

object_name: Hodgkin Disease


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: GTOPDB:12990

subject_name: sintilimab

object_name: carcinoma of biliary tract


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:145499

subject_name: Donepezil

object_name: aphasia


subject: CHEBI:145499

object_name: Stroke (heart beat)


subject: CHEBI:145499

object_name: Stroke, CTCAE


subject: CHEBI:59594

subject_name: Colesevelam

object_name: hyperglycemia


subject: CHEBI:59594

object_name: Hyperglycemia, CTCAE


subject: CHEBI:59594

object_name: Glucose in blood specimen above reference range


subject: CHEBI:59594

object_name: inherited lipid metabolism disorder


subject: CHEBI:59594

object_name: Dyslipidemia


subject: CHEBI:59594

object_name: hyperlipidemia


subject: CHEBI:59594

object_name: hyperlipoproteinemia


subject: CHEBI:59594

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:59594

object_name: Serum lipids high (finding)


subject: CHEBI:601027

subject_name: Aliskiren

object_name: arteriosclerosis disorder


subject: CHEBI:601027

object_name: atherosclerosis


subject: CHEBI:149504

object_name: diabetes mellitus


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: pancreatic neoplasm


subject: PR:000014196

object_name: exocrine pancreatic carcinoma


subject: PR:000014196

object_name: malignant pancreatic neoplasm


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: DRUGBANK:DB10555

subject_name: Pecan

object_name: cardiovascular disorder


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: Kaposi Sarcoma


subject: UMLS:C5203350

subject_name: Digoxin Liquid Injection

object_name: atrial fibrillation


subject: UMLS:C5203350

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C5203350

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0498839

subject_name: INJECTION, DIGOXIN, UP TO 0.5 MG ADMINISTERED


subject: UMLS:C0498839


subject: UMLS:C0498839


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: UMLS:C0218184

subject_name: Kogenate

object_name: hemophilia


subject: UMLS:C0961271


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5204132

subject_name: Copper Cu 64-DOTA-ECL1i

object_name: heart disorder


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: inflammatory spondylopathy


subject: CHEBI:71200

object_name: spondyloarthropathy


subject: CHEBI:125628

subject_name: Alisertib

object_name: digestive system cancer


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:15640

subject_name: Leucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: relapsing polychondritis


subject: UMLS:C0378942


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: plasma cell myeloma


subject: UMLS:C3541401

subject_name: Bisphosphonate drugs affecting bone structure and mineralization


subject: MESH:D004164

subject_name: Diphosphonates


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: pyelonephritis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: Rotavirus infection


subject: CHEBI:94807

object_name: diarrhea


subject: CHEBI:94807

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:94807

object_name: Diarrhea, CTCAE


subject: CHEBI:9168

subject_name: Sirolimus

object_name: fibromatosis


subject: CHEBI:9168

object_name: desmoid tumor


subject: CHEBI:9168

object_name: Desmoid tumor


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:23066

subject_name: cephalosporin

object_name: Mycoplasma pneumoniae pneumonia


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:63613

subject_name: Nevirapine

object_name: AIDS


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: alopecia totalis


subject: CHEBI:71200

object_name: alopecia universalis congenita


subject: CHEBI:71200

object_name: alopecia areata 1


subject: CHEBI:71200

object_name: alopecia universalis


subject: UMLS:C5555004

subject_name: Izalontamab

object_name: non-small cell lung carcinoma


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: atopic eczema


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: appendicitis


subject: UNII:L500PR95QA

object_name: Appendicitis, CTCAE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:76842

object_name: kidney failure


subject: CHEBI:76842

object_name: Renal Failure, CTCAE


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Thoracic Diseases


subject: UMLS:C4086546

object_name: Local anaesthetics causing adverse effects in therapeutic use


subject: UMLS:C4086546

object_name: opiate dependence


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: glioblastoma


subject: UNII:6QVL057INT

object_name: Childhood Glioblastoma


subject: UNII:6QVL057INT

object_name: adult glioblastoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4725065

subject_name: WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401


subject: UMLS:C4725065


subject: UMLS:C4725065


subject: UMLS:C3896834

subject_name: Dna plasmid encoding interleukin-12 ino-9012


subject: UMLS:C3896834


subject: UMLS:C3896834


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Shock


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: Traumatic hemorrhage


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4053621

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:3223

subject_name: Buspirone

object_name: Dyspnea


subject: CHEBI:3223

object_name: Dyspnea, CTCAE


subject: CHEBI:3223

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:3223

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:3223

object_name: Pulmonary Complication


subject: UMLS:C0085980

object_name: HIV infection


subject: UMLS:C0795633

subject_name: insulin isophane, human

object_name: type 2 diabetes mellitus


subject: UMLS:C0795633

object_name: Diabetes


subject: UMLS:C0795633

object_name: diabetes mellitus


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: endogenous depression


subject: CHEBI:36005

object_name: major depressive disorder


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: PUBCHEM.COMPOUND:10303232

object_name: nicotine dependence


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: grade III glioma


subject: UMLS:C0919079

object_name: grade II glioma


subject: UMLS:C0919079

object_name: Diffuse Astrocytoma, IDH-Wildtype


subject: UMLS:C0919079

object_name: IDH-wildtype anaplastic astrocytoma


subject: UMLS:C0919079

object_name: Childhood Oligoastrocytoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:75929

object_name: delusional disorder


subject: CHEBI:75929

object_name: schizoaffective disorder


subject: CHEBI:75929

object_name: schizophrenia 18


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: CHEBI:40009


subject: CHEBI:49603

subject_name: Lapatinib

object_name: urinary bladder carcinoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:70839

object_name: non-small cell lung carcinoma


subject: CHEBI:70839

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:70839

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C3896819

object_name: hepatitis C


subject: CHEBI:59594

subject_name: Colesevelam

object_name: coronary artery disorder


subject: CHEBI:59594

object_name: coronary atherosclerosis


subject: CHEBI:59594

object_name: arteriosclerosis disorder


subject: CHEBI:59594

object_name: atherosclerosis


subject: CHEBI:59594

object_name: carotid artery disorder


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:17154


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: liver carcinoma


subject: CHEBI:80774

subject_name: taurursodiol


subject: CHEBI:188074

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:188074

object_name: metabolic syndrome X


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: cervical cancer


subject: GTOPDB:13792

object_name: cervical carcinoma


subject: GTOPDB:13792

object_name: Neoplasm Recurrence, Local


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: CHEBI:31355

subject_name: Carboplatin


subject: UMLS:C5853388

object_name: anti-NMDA receptor encephalitis


subject: UMLS:C5853388

object_name: autoimmune encephalitis


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: meningeal tuberculosis


subject: CHEBI:41879

object_name: tuberculosis


subject: CHEBI:41879

object_name: drug-induced liver injury


subject: CHEBI:41879

object_name: HIV infection


subject: CHEBI:41879

object_name: immune reconstitution inflammatory syndrome


subject: CHEBI:136037

subject_name: Corticorelin

object_name: brain edema


subject: CHEBI:136037

object_name: brain neoplasm


subject: UMLS:C1515367

subject_name: Xerecept


subject: UMLS:C1515367


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: bladder disease


subject: PUBCHEM.COMPOUND:18319735

object_name: urinary system disorder


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Coronary artery stent thrombosis


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: wet macular degeneration


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:91414

subject_name: Adavosertib

object_name: glioblastoma


subject: CHEBI:91414

object_name: Childhood Glioblastoma


subject: CHEBI:91414

object_name: adult glioblastoma


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: UMLS:C5226733

object_name: peanut allergy


subject: MESH:C000723005

subject_name: CV0501 COVID-19 vaccine


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Inflammation


subject: CHEBI:9434

object_name: end stage renal failure


subject: CHEBI:9434

object_name: Chronic uremia


subject: CHEBI:3380

subject_name: Captopril


subject: CHEBI:3380


subject: CHEBI:3380


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C0006938


subject: UMLS:C0006938


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: Osteopenia


subject: MESH:D004164

subject_name: Diphosphonates


subject: UMLS:C2267018

subject_name: Bisphosphonate [EPC]


subject: CHEBI:66910

subject_name: Axitinib

object_name: Advanced cancer


subject: CHEBI:66910

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:66910

object_name: Metastatic Renal Cell Cancer


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:233362

object_name: malignant neoplasm of breast stage IV


subject: PUBCHEM.COMPOUND:18319735

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:18319735

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:18319735

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:18319735

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:18319735

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:18319735

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:18319735

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:18319735

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:18319735

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:18319735

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:18319735

object_name: small cell carcinoma


subject: PUBCHEM.COMPOUND:18319735

object_name: small cell lung carcinoma


subject: DRUGBANK:DB17524

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17524

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17524

object_name: Solid Neoplasm


subject: DRUGBANK:DB17524

object_name: cancer


subject: DRUGBANK:DB17524

object_name: neoplasm


subject: DRUGBANK:DB17524

object_name: carcinoma


subject: UNII:YI437801BE

subject_name: Mogamulizumab


subject: UNII:YI437801BE


subject: UNII:YI437801BE


subject: UNII:YI437801BE


subject: UNII:YI437801BE


subject: UNII:YI437801BE


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UNII:1BEM3U6LQQ

subject_name: rehmannia root

object_name: Diabetic foot ulcer


subject: UNII:922OP8YUPF

subject_name: Huang Qi


subject: CHEBI:77942

subject_name: Tavaborole

object_name: tinea unguium


subject: CHEBI:77942

object_name: Onychomycosis due to dermatophyte


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: cervical cancer


subject: UNII:5S371K6132

object_name: cervical carcinoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Abortion early


subject: CHEBI:63610

subject_name: Misoprostol


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: transient ischemic attack


subject: PUBCHEM.COMPOUND:155543961

object_name: Ischemic stroke


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UNII:C21EZR41AY

subject_name: Zalypsis

object_name: endometrial cancer


subject: UNII:C21EZR41AY

object_name: uterine corpus cancer


subject: UNII:C21EZR41AY

object_name: endometrial carcinoma


subject: UNII:C21EZR41AY


subject: UNII:T8B2ORP1DW

subject_name: Evinacumab

object_name: hypertriglyceridemia


subject: UNII:T8B2ORP1DW

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: cocaine abuse


subject: UNII:Z39Q6AB0ZR

subject_name: TANFANERCEPT

object_name: dry eye syndrome


subject: UNII:Z39Q6AB0ZR

object_name: Dry Eye, CTCAE


subject: UNII:Z39Q6AB0ZR

object_name: Dryness of eye


subject: CHEBI:3766

subject_name: Clozapine

object_name: intellectual disability


subject: CHEBI:60799

subject_name: Esketamine

object_name: Maternity blues


subject: UMLS:C4087030

object_name: Lennox-Gastaut syndrome


subject: UMLS:C4087030

object_name: Dravet syndrome


subject: UMLS:C4087030

object_name: developmental and epileptic encephalopathy, 6A


subject: UMLS:C4087030

object_name: epilepsy


subject: CHEBI:15365

subject_name: Aspirin

object_name: Hemorrhage


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: graft versus host disease


subject: CHEBI:73604

object_name: Cyclophosphamide adverse reaction


subject: CHEBI:94534

subject_name: olanzapine

object_name: early-onset schizophrenia


subject: RXCUI:2611259

subject_name: bupropion / dextromethorphan Extended Release Oral Tablet

object_name: opioid use


subject: RXCUI:2611259

object_name: opiate dependence


subject: RXCUI:2611259

object_name: Substance Use Disorders


subject: RXCUI:2611259

object_name: Addiction


subject: UMLS:C4733615

object_name: Stomach cancer


subject: UMLS:C4733615

object_name: gastric cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: hepatitis B


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C0003364

subject_name: Antihypertensive Agents

object_name: aldosterone-producing adrenal cortex adenoma


subject: UMLS:C0003364

object_name: Conn Adenoma


subject: CHEBI:66964

subject_name: Dronabinol

object_name: TRAUMA/INJURY PROBLEM


subject: CHEBI:57986

object_name: keratoconus


subject: CHEBI:57986

object_name: corneal ectasia


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: brain neoplasm


subject: CHEBI:28240

object_name: glioblastoma


subject: CHEBI:28240

object_name: Childhood Glioblastoma


subject: CHEBI:28240

object_name: adult glioblastoma


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: CHEBI:36386


subject: CHEBI:36386


subject: CHEBI:36386


subject: CHEBI:31355

subject_name: Carboplatin

object_name: esophageal small cell neuroendocrine carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C4329337

subject_name: TAB 001


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:31348

object_name: advanced adult primary liver cancer


subject: CHEBI:31348

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:38940

subject_name: Sunitinib

object_name: adult hepatocellular carcinoma


subject: CHEBI:38940

object_name: liver carcinoma


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:49603

subject_name: Lapatinib

object_name: colorectal cancer


subject: CHEBI:49603

object_name: colorectal carcinoma


subject: CHEBI:49603

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Recurrent spontaneous abortion


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C4054250

object_name: Neck Carcinoma


subject: UMLS:C4054250

object_name: head and neck neoplasm


subject: UMLS:C4054250

object_name: head and neck cancer


subject: CHEBI:142094

subject_name: (S)-S-adenosyl-L-methionine zwitterion

object_name: alcoholic liver diseases


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:67040

subject_name: Ademetionine


subject: PUBCHEM.COMPOUND:164886680

subject_name: Certepetide

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: Extrahepatic Cholangiocarcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: intrahepatic cholangiocarcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: gallbladder carcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: gallbladder cancer


subject: PUBCHEM.COMPOUND:164886680

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164886680

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164886680

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164886680

object_name: Stage III Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164886680

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164886680

object_name: bile duct carcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: bile duct cancer


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: CHEBI:28661

subject_name: Gamolenic acid

object_name: chronic childhood arthritis


subject: CHEBI:28661

object_name: juvenile idiopathic arthritis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C0962969

subject_name: RAD 001


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: chronic bronchitis


subject: CHEBI:91407

subject_name: Momelotinib


subject: CHEBI:91407

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:91407

object_name: myelofibrosis


subject: UMLS:C0962969

object_name: carcinoma


subject: UMLS:C0962969

object_name: esophageal adenocarcinoma


subject: UMLS:C0962969

object_name: lung adenocarcinoma


subject: UMLS:C0962969

object_name: cervical adenocarcinoma


subject: UMLS:C0962969

object_name: adenocarcinoma


subject: UMLS:C0962969

object_name: bile duct adenocarcinoma


subject: UMLS:C0962969

object_name: gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: MESH:C000618192

object_name: Vaccinia virus infection


subject: MESH:C000618192

object_name: monkeypox


subject: MESH:C000618192

object_name: smallpox


subject: MESH:C000618192

object_name: cowpox


subject: CHEBI:16382

subject_name: Iodide

object_name: Transient hypothyroxinemia


subject: CHEBI:6801

subject_name: Metformin

object_name: Heart Failure, CTCAE


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: pediatric osteosarcoma


subject: UNII:KXG2PJ551I

object_name: Osteosarcoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:231651

object_name: acute myeloid leukemia


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:75998

subject_name: Trametinib


subject: UMLS:C1879681

subject_name: Prochymal

object_name: graft versus host disease


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Exposure to heat


subject: RXCUI:393355

subject_name: betamethasone / calcipotriene Topical Ointment

object_name: psoriasis vulgaris


subject: UNII:73B0K5S26A

subject_name: Belimumab


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: HIV infection


subject: CHEBI:3638

subject_name: Chloroquine

object_name: metastatic malignant neoplasm in the brain


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: triple-negative breast carcinoma


subject: GTOPDB:9758

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hip dysplasia


subject: UNII:G8FR269QPQ

subject_name: FOSCICLOPIROX

object_name: Refractory acute myeloid leukemia


subject: UNII:G8FR269QPQ

object_name: Recurrent Acute Myeloid Leukemia


subject: DRUGBANK:DB18772

subject_name: Fosciclopirox


subject: DRUGBANK:DB18772


subject: CHEBI:27732

subject_name: Caffeine

object_name: alcohol abuse


subject: CHEBI:27732

object_name: alcohol dependence


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:50777

subject_name: Etonogestrel


subject: CHEBI:367163

subject_name: Darunavir

object_name: Uses contraception (finding)


subject: CHEBI:68606

subject_name: Rilpivirine


subject: GTOPDB:9758

object_name: Childhood Breast Carcinoma


subject: GTOPDB:9758

object_name: breast carcinoma


subject: GTOPDB:9758

object_name: breast cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: CHEBI:75012

subject_name: Val-Ile

object_name: asthma


subject: CHEBI:4875

subject_name: Etanercept

object_name: SAPHO syndrome


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C5556548

subject_name: CD122-selective IL-2/Anti-CD25 Antibody-like Fusion Protein ANV419

object_name: Advanced Melanoma


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate

object_name: cervical cancer


subject: CHEBI:31587

object_name: cervical carcinoma


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0304475

subject_name: Potassium supplement

object_name: Renal Function


subject: UMLS:C0304475

object_name: Blood Pressure Finding


subject: UMLS:C0304475

object_name: Systemic arterial pressure


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: CHEBI:26216


subject: CHEBI:26216


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: CHEBI:8802

subject_name: Remifentanil

object_name: congenital alveolar dysplasia


subject: CHEBI:8802

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:8802

object_name: adult acute respiratory distress syndrome


subject: CHEBI:8802

object_name: newborn respiratory distress syndrome


subject: UMLS:C5782830

subject_name: ROPivacaine 0.5% injectable solution

object_name: Post-Operative Pain


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Uterine atony with hemorrhage


subject: UMLS:C1144384

subject_name: G-3139 oligonucleotide

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1144384

object_name: chronic leukemia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: lymphoid leukemia


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: familial Dupuytren contracture


subject: UMLS:C2740325

object_name: palmar fibromatosis


subject: UMLS:C2740325

object_name: Dupuytren's Disease


subject: CHEBI:36946

subject_name: thiourea

object_name: hypogonadism


subject: CHEBI:31859

subject_name: Modafinil

object_name: cancer


subject: CHEBI:31859

object_name: neoplasm


subject: UMLS:C3661049

object_name: fragile X syndrome


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: endocrine exophthalmos


subject: MESH:C000851

subject_name: flupentixol, melitracen drug combination


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Malignant cachexia


subject: CHEBI:4551

subject_name: Digoxin

object_name: Drug Interactions


subject: CHEBI:9241

subject_name: Spironolactone


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Graft Rejection


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: stroke disorder


subject: CHEBI:74705

object_name: cerebrovascular disorder


subject: CHEBI:74705

object_name: Stroke (heart beat)


subject: CHEBI:74705

object_name: Stroke, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: Craving


subject: UNII:V038D626IF

object_name: Stress


subject: CHEBI:16302

object_name: vitamin A deficiency


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:80343

subject_name: Mecasermin

object_name: Rett syndrome


subject: CHEBI:93775

subject_name: Amethopterin

object_name: adult dermatomyositis


subject: CHEBI:93775

object_name: dermatomyositis


subject: CHEBI:93775

object_name: polymyositis


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: UMLS:C5198622

object_name: kidney failure


subject: CHEBI:66910

subject_name: Axitinib

object_name: Neoplasm Metastasis


subject: UMLS:C5446607

subject_name: Axl/Mer Inhibitor PF-07265807


subject: UNII:IUQ0ZOS73R


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB


subject: UMLS:C1550146

subject_name: Other - Substance Type

object_name: Birthing Labor


subject: UMLS:C1550146

object_name: Labor Pain


subject: UMLS:C5773278

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5773278

object_name: obesity


subject: UMLS:C5773278

object_name: Obesity, CTCAE


subject: UMLS:C5773278

object_name: liver disorder


subject: UMLS:C3490133

object_name: carcinoma


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: neuromuscular disease


subject: UMLS:C0919075

object_name: AIDS dementia


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: Infection


subject: UMLS:C0250480

object_name: infectious disease


subject: UMLS:C0250480

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Vomiting, CTCAE


subject: PUBCHEM.COMPOUND:160883

object_name: Vomiting


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: bladder transitional cell carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Bladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Bladder Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: transitional cell carcinoma


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:28X28X9OKV

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:6Y83I5F10I

subject_name: INSULIN PEGLISPRO

object_name: type 2 diabetes mellitus


subject: UMLS:C4550895

subject_name: Insulin peglispro


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Stress


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:135207

subject_name: Clofedanol

object_name: schizophrenia


subject: CHEBI:135207

object_name: schizoaffective disorder


subject: CHEBI:135207

object_name: schizophrenia 18


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:182913

subject_name: Dexpramipexole


subject: CHEBI:182913


subject: CHEBI:182913


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:8356


subject: GTOPDB:8313

subject_name: talazoparib

object_name: breast neoplasm


subject: UMLS:C0982327

subject_name: PEGINTERFERON

object_name: hepatitis B


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IB pancreatic cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IIB pancreatic cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IIA pancreatic cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:PQX0D8J21J

object_name: neoplasm


subject: UNII:PQX0D8J21J

object_name: Tumor Mass


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: UNII:8M7YSN2KII


subject: UNII:8M7YSN2KII

object_name: colorectal cancer


subject: UNII:8M7YSN2KII

object_name: colorectal carcinoma


subject: UNII:8M7YSN2KII

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: PUBCHEM.COMPOUND:53427024

subject_name: Arimoclomol

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:94705

object_name: tinea unguium


subject: CHEBI:9448

subject_name: Terbinafine


subject: UNII:GGK40O1O85

object_name: type 2 diabetes mellitus


subject: CHEBI:229643

subject_name: Zavegepant

object_name: asthma


subject: CHEBI:50172

subject_name: acitretin

object_name: melanoma


subject: CHEBI:50174


subject: PUBCHEM.COMPOUND:3222

object_name: ventricular septal defect


subject: PUBCHEM.COMPOUND:3222

object_name: heart failure


subject: PUBCHEM.COMPOUND:3222

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:3222

object_name: congenital heart disease


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:52763

object_name: ulcerative colitis


subject: CHEBI:82960

subject_name: Raltegravir

object_name: AIDS


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371

object_name: adamantinous craniopharyngioma


subject: CHEBI:35480

subject_name: analgesic

object_name: Chronic pain


subject: CHEBI:35480

object_name: Pain, Intractable


subject: CHEBI:35480

object_name: Chronic nonmalignant pain


subject: UMLS:C1446917

subject_name: Trigonella foenum-graecum antigen

object_name: diabetes mellitus


subject: MESH:C056164

subject_name: fenugreek seed meal


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Acquired methemoglobinemia


subject: CHEBI:43830

subject_name: Methylthioninium


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265

object_name: acute biphenotypic leukemia


subject: CHEBI:94265

object_name: mixed phenotype acute leukemia


subject: CHEBI:94265

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:50733

subject_name: nutraceutical

object_name: anus cancer


subject: CHEBI:50733

object_name: anal carcinoma


subject: CHEBI:50733

object_name: Childhood Breast Carcinoma


subject: CHEBI:50733

object_name: breast carcinoma


subject: CHEBI:50733

object_name: breast cancer


subject: CHEBI:3374

subject_name: Capsaicin

object_name: rhinitis


subject: MESH:C018577

subject_name: lactoserum

object_name: bacterial vaginosis


subject: CHEBI:82405

subject_name: Benzoyl peroxide

object_name: Cutibacterium acnes infection


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: chronic kidney disease


subject: CHEBI:94556

subject_name: Nifuroxazide

object_name: hepatic encephalopathy


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Incision site discomfort


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: impotence


subject: CHEBI:7986

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:7986

object_name: Erectile dysfunction


subject: CHEBI:7986

object_name: prostate carcinoma


subject: CHEBI:7986

object_name: prostate cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Classical Hodgkin lymphoma refractory


subject: UNII:DPT0O3T46P

object_name: Relapsing classical Hodgkin lymphoma


subject: UNII:9X4R4A4HQQ

subject_name: BERAHYALURONIDASE ALFA

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UNII:9X4R4A4HQQ


subject: UNII:9X4R4A4HQQ

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UNII:9X4R4A4HQQ


subject: UMLS:C5855305

subject_name: Berahyaluronidase Alfa


subject: UMLS:C5855305


subject: UMLS:C5855305


subject: UMLS:C5855305


subject: UMLS:C4687467

subject_name: Anti-IL17A Monoclonal Antibody CJM112

object_name: plasma cell myeloma


subject: CHEBI:193137


subject: UMLS:C2984020


subject: UMLS:C4053607


subject: CHEBI:9150

subject_name: Simvastatin

object_name: traumatic encephalopathy


subject: CHEBI:9150

object_name: traumatic brain injury


subject: UMLS:C1170076

subject_name: Avandamet

object_name: Childhood Breast Carcinoma


subject: UMLS:C1170076

object_name: breast carcinoma


subject: UMLS:C1170076

object_name: breast cancer


subject: CHEBI:73893

subject_name: Gly-D-Asp

object_name: herpes simplex


subject: CHEBI:73804

subject_name: Gly-Asp


subject: CHEBI:33375

subject_name: Gadolinium


subject: UMLS:C1328725

subject_name: galactomannan derivative


subject: PR:000012224

subject_name: glycodelin


subject: UMLS:C5203047

subject_name: G-Series Nerve Agent GD


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: MESH:C000722927

object_name: Advanced breast cancer


subject: MESH:C000722927

object_name: Malignant neoplasm of female breast


subject: MESH:C000722927

object_name: female breast carcinoma


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: DRUGBANK:DB18177

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: DRUGBANK:DB18177

object_name: Unresectable Melanoma


subject: DRUGBANK:DB18177

object_name: metastatic melanoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4287789

object_name: rheumatoid arthritis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:41879

object_name: Fatigue


subject: CHEBI:41879

object_name: Advanced cancer


subject: CHEBI:41879

object_name: refractory malignant neoplasm


subject: CHEBI:41879

object_name: Recurrent Malignant Neoplasm


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Childhood Neuroblastoma


subject: UNII:M89N0Q7EQR

object_name: neuroblastoma


subject: PR:000001379


subject: PR:000001379


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: cancer


subject: UMLS:C0042210

subject_name: Vaccines

object_name: adult acute myeloid leukemia


subject: UMLS:C0030956

subject_name: Peptides


subject: PR:000018264

subject_name: proteolytic cleavage product


subject: UMLS:C5417812

subject_name: Finotonlimab

object_name: head and neck squamous cell carcinoma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: temporomandibular joint disorder


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Snoring


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: craniosynostosis


subject: CHEBI:94518

object_name: Premature closure of cranial sutures


subject: GTOPDB:4934

subject_name: G-CSF

object_name: myeloproliferative neoplasm


subject: GTOPDB:4934

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: GTOPDB:4934

object_name: acute leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354


subject: PR:000013366

subject_name: proteasome subunit alpha type-7


subject: PR:000013366


subject: PR:000013366

object_name: Myelodysplasia


subject: PR:000013366


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:9570

subject_name: Thiotepa


subject: PUBCHEM.COMPOUND:53395091

object_name: heart disorder


subject: PUBCHEM.COMPOUND:53395091

object_name: Increased reactive oxygen species production


subject: PUBCHEM.COMPOUND:53395091

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:53395091

object_name: Diabetes


subject: PUBCHEM.COMPOUND:53395091

object_name: diabetes mellitus


subject: CHEBI:16375

subject_name: D-Cysteine


subject: CHEBI:16375


subject: CHEBI:16375


subject: CHEBI:16375


subject: CHEBI:16375


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:16811

subject_name: Racemethionine


subject: CHEBI:16811


subject: CHEBI:16811


subject: CHEBI:16811


subject: CHEBI:16811


subject: UMLS:C0034504

subject_name: racemethionine


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: CHEBI:90227

subject_name: Selumetinib

object_name: thyroid tumor


subject: CHEBI:90227

object_name: thyroid gland carcinoma


subject: CHEBI:90227

object_name: thyroid cancer


subject: CHEBI:68647

subject_name: Regorafenib

object_name: metastatic melanoma


subject: CHEBI:68647

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:135901

subject_name: lanreotide

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C4721901

subject_name: Lanreotide Autogel


subject: CHEBI:29999

subject_name: L-serine residue

object_name: hereditary sensory and autonomic neuropathy type 1


subject: CHEBI:17115

subject_name: Serine


subject: UMLS:C3272661

subject_name: Muscadine Grape Skin Extract

object_name: Advanced cancer


subject: UMLS:C3272661

object_name: Embolism, Tumor


subject: UMLS:C3272661

object_name: Unresectable Malignant Neoplasm


subject: UMLS:C5555594

subject_name: Lutetium Lu-177 PNT2002

object_name: adrenal cortex carcinoma


subject: UMLS:C5555594

object_name: adenoid cystic carcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Childhood Solid Neoplasm


subject: CHEBI:5801

object_name: Adult Solid Neoplasm


subject: CHEBI:5801

object_name: Solid Neoplasm


subject: CHEBI:188637

subject_name: Evacetrapib

object_name: hyperlipidemia


subject: CHEBI:188637

object_name: hyperlipoproteinemia


subject: CHEBI:188637

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:188637

object_name: Serum lipids high (finding)


subject: UNII:51XWV9K850


subject: UNII:51XWV9K850


subject: UNII:51XWV9K850


subject: UNII:51XWV9K850


subject: CHEBI:134708

subject_name: Saroglitazar

object_name: Fatty Liver


subject: PR:P01892

subject_name: HLA class I histocompatibility antigen, A-2 alpha chain (human)

object_name: pancreatic neoplasm


subject: PR:P01892

object_name: exocrine pancreatic carcinoma


subject: PR:P01892

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108918

subject_name: CHAMOMILE

object_name: Recurrent abdominal pain


subject: UMLS:C1570551

object_name: eating disorder


subject: UNII:GE077RPG04

subject_name: RACLOPRIDE C 11


subject: CHEBI:42724

subject_name: levamfetamine


subject: CHEBI:35338

subject_name: amphetamines


subject: CHEBI:132233

subject_name: Amphetamine


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: leukemia


subject: UMLS:C0919079

object_name: childhood leukemia


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Childhood Neuroblastoma


subject: CHEBI:135515

object_name: neuroblastoma


subject: PR:000001786


subject: PR:000001786


subject: PR:000001786

object_name: adult lymphoma


subject: PR:000001786

object_name: lymphoma


subject: PR:000001786

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C2698141


subject: UMLS:C2698141


subject: UMLS:C2698141


subject: UMLS:C2698141


subject: UMLS:C2698141


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: ADHF


subject: CHEBI:7986

object_name: Intravascular hemolysis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Tubular breast cancer stage III


subject: CHEBI:31355

object_name: Tubular breast cancer stage II


subject: CHEBI:31355

object_name: Mucinous breast cancer stage II


subject: CHEBI:31355

object_name: invasive ductal breast carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: paraganglioma